# Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease

> **NCT05068830** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Norwegian University of Science and Technology** · enrollment: 60 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** ExPlas
- **DRUG:** Octaplasma
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05068830
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-17
- **Primary completion:** 2027-03-01
- **Final completion:** 2031-03-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05068830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05068830, "Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05068830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*